Navigation Links
Cardium's InnerCool Reports on Expanding Use of Therapeutic Hypothermia
Date:1/29/2009

hemic events such as cardiac arrest or stroke, and to potentially lessen or prevent associated injuries such as adverse neurological outcomes. For more information about Cardium's InnerCool subsidiary and patient temperature modulation, including InnerCool's new RapidBlue(TM) System, which just received FDA clearance, and its CoolBlue(TM) System, please visit www.innercool.com.

Cardium also has two biologic candidates in clinical development. Cardium's Tissue Repair Company subsidiary (TRC) is focused on the development of growth factor therapeutics for the treatment of severe chronic diabetic wounds. TRC's lead product candidate, Excellarate(TM), is a DNA-activated collagen gel for topical treatment formulated with an adenovector delivery carrier encoding human platelet-derived growth factor-BB (PDGF-BB). Excellarate(TM) is initially being developed to be administered once or twice for the potential treatment of non-healing diabetic foot ulcers. Other potential applications for TRC's Gene Activated Matrix(TM) (GAM) technology include therapeutic angiogenesis (cardiovascular ischemia, peripheral arterial disease) and orthopedic products, including hard tissue (bone) and soft tissue (ligament, tendon, cartilage) repair. For more information about Cardium's Tissue Repair Company subsidiary, please visit www.t-r-co.com.

Cardium's Generx product candidate (alferminogene tadenovec, Ad5FGF-4) is a DNA-based growth factor therapeutic being developed for potential use by interventional cardiologists as a one-time treatment to promote and stimulate the growth of collateral circulation in the hearts of patients with ischemic conditions such as recurrent angina. For more information about Cardium Therapeutics and its businesses, products and therapeutic candidates, please visit www.
'/>"/>

SOURCE Cardium Therapeutics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine news :

1. Cardiums InnerCool Announces Launch of New Enhanced Website
2. Cardium Announces InnerCools Endovascular Cooling to be Featured on Science Channels Series Cool Stuff: How It Works
3. Cardiums InnerCool Therapies Unit Announces Australian Distribution Agreement for CoolBlue and Rapid Blue Systems
4. Zimmer Reports Fourth Quarter and 2008 Financial Results
5. Nutraceutical Reports Fiscal 2009 Q1 Results
6. Lilly Reports Fourth-Quarter and Full-Year 2008 Results
7. NBTY Reports First Quarter Results
8. Covance Reports Fourth Quarter and Full-Year 2008 Results
9. WellPoint Reports Fourth Quarter and Full Year 2008 Results
10. Amylin Pharmaceuticals Reports 2008 Financial Results
11. MedPro Reports 127 Percent Revenue Growth in 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... ... September 03, 2015 , ... While bariatric surgeon Michael Feiz, M.D., ... when preparing for a bariatric procedure, some patients have been recently asking further questions ... instructions typical for many types of surgery that should be followed in the days ...
(Date:9/3/2015)... ... September 03, 2015 , ... Allied Anesthesia is proud to announce a ... norm not the exception. , St. Jude was recently named one of the nation’s ... making it one of only 10 hospitals in the state to earn the distinction. ...
(Date:9/3/2015)... ... , ... TransPack Toon gives users a set of 90 cartoon transitions for ... in 30 different styles. Presets range from snow, underwater, forest, futuristic, city and many ... features 90 cartoon transitions from 30 unique styles. Editors can choose between line ...
(Date:9/3/2015)... (PRWEB) , ... September 03, 2015 , ... ... Inc. , a privately held medical technology company that will bring low-cost cancer ... markets worldwide. , Preora’s proprietary and automated technology platform detects and measures ...
(Date:9/3/2015)... Buffalo, New York (PRWEB) , ... September 03, 2015 , ... ... We Do”. William Mattar, Esq. believes this does not stop at any certain ... closed captioning to its newly produced one-minute, thirty-, fifteen- and ten-second TV commercials. , ...
Breaking Medicine News(10 mins):Health News:Dr. Feiz and Associates Answer August's ‘Patient Submitted Question of the Month’: “How Can I Prepare for Weight Loss Surgery” 2Health News:Allied Anesthesia Physicians Announce Partnership with St. Jude 2Health News:Allied Anesthesia Physicians Announce Partnership with St. Jude 3Health News:Pixel Film Studios Releases TransPack Toon, a New FCPX Transition 2Health News:Preora Diagnostics to Commercialize Cancer Pre-screening Tests 2Health News:Preora Diagnostics to Commercialize Cancer Pre-screening Tests 3Health News:Law Firm Focused on “Helping People” Continues to Expand on Vision 2
... A nationwide study examining the safety of Tasers ... safe, causing a low occurrence of serious injuries., This ... associated with Tasers. It is the first injury epidemiology ... assess the overall risk and severity of injuries in ...
... no significant change in the quality of care for ... Prescription Drug, Improvement, and Modernization Act of 2003 (MMA) ... 2007 issue of CANCER, a peer-reviewed journal of the ... Friedman from the Duke Clinical Research Institute in Durham, ...
... -- Cancer patients receiving chemotherapy have not noticed a ... of the Medicare Prescription Drug, Improvement and Modernization Act ... government reimbursement to oncologists, according to a new study ... (DCRI). , Critics of the MMA often said that ...
... - Report Suggests Millions of Sports Persons are Suffering ... health reveals that men and,women who aim to keep fit, ... of all active respondents who took part in the survey ... seem to be a common occurrence for the nations top,sports ...
... recent months, a,perfect storm of new technology and research ... and genetics, writes Lee Silver, a professor,of molecular biology ... heredity is the result of an incredibly complex interplay,among ... different,genes and even the vast stretches of "junk DNA" ...
... today expressed their great disappointment in President Bushs veto ... Health Insurance Program (SCHIP). The sentiment was expressed ... by David C. Dale, MD, FACP, president of the ... the 124,000 internal medicine physicians and medical student members ...
Cached Medicine News:Health News:Nationwide independent Taser study results suggest devices are safe 2Health News:Patients perceived cancer care unaffected by lower Medicare reimbursements 2Health News:Medicare modernization act did not change chemotherapy as feared 2Health News:More Damage Than Good? Shock Survey Reveals Sport can Actually be bad for Your Joints 2Health News:More Damage Than Good? Shock Survey Reveals Sport can Actually be bad for Your Joints 3Health News:NEWSWEEK International Editions: Highlights and Exclusives, OCT. 15, 2007 Issue 2Health News:NEWSWEEK International Editions: Highlights and Exclusives, OCT. 15, 2007 Issue 3Health News:NEWSWEEK International Editions: Highlights and Exclusives, OCT. 15, 2007 Issue 4Health News:'Great disappointment' in veto of SCHIP legislation expressed by American College of Physicians 2
(Date:9/3/2015)... -- Research and Markets( http://www.researchandmarkets.com/research/fw4ctl/investigation ) ... on China,s Entecavir Market, 2010-2019" report to their ... hepatitis B virus (HBV) exceeds 100 million in ... from chronic Hepatitis B. About 0.5 million Chinese is ... caused by chronic Hepatitis B, causing a loss of ...
(Date:9/3/2015)... , Sep. 03, 2015 ... addition of the "Investigation Report on China,s Raloxifene ... According to the statistics, over 200 million people suffer ... and above in China , 50% ... is 30%-50% among women aged 60 and above. ...
(Date:9/3/2015)... 2015 China,s startup ... Patch, a wearable medical device that can continuously monitor ... providing safety guidance for pregnant women. The device will ... device, which measures 4 centimeters in diameter, is as ... more than an Apple earphone cord. The small and ...
Breaking Medicine Technology:China Entecavir Market Report 2010-2019 2Investigation Report on China's Raloxifene Market, 2015-2019 2Modoo to Debut at Kickstarter: First Device on the Market that Enables Continuous Monitoring of Fetal Heart Rate and Fetal Movement 2
... (Nasdaq CM: INSM), a biopharmaceutical company, will host a ... AM ET, to discuss its financial results for the ... quarterly financial results press release before the market opens ... the live conference call, please dial 800-901-5213 (U.S. callers) ...
... Pharmaceuticals, Inc. (Nasdaq: ALXA ) announced today that ... 31, 2012, on Thursday, May 10, 2012, following the close ... investor conference call and live webcast to discuss the financial ... Time / 2:00 p.m. Pacific Time on the same date. The ...
Cached Medicine Technology:Insmed to Host 2012 First Quarter Earnings Conference Call 2Insmed to Host 2012 First Quarter Earnings Conference Call 3Alexza to Announce 2012 First Quarter Financial Results on Thursday, May 10, 2012 2Alexza to Announce 2012 First Quarter Financial Results on Thursday, May 10, 2012 3
AxSYM Myoglobin is a Microparticle Enzyme Immunoassay (MEIA) for the quantitative determination of myoglobin in human serum or plasma on the AxSYM System....
... VITROS ECi brings true automation and ... testing. Highly sensitive assays for thyroid, ... bone metabolism testing are currently available, ... The VITROS ECi can simultaneously process ...
... Tests are used by hospitals, clinics and ... human health conditions. The majority of these ... which are offered in strip, cassette, and ... through membrane tests are also available. All ...
ELISA kit for detection of the cardiac marker Myoglobin. Kit features interchangeable reagents, E-Z Process performed at room temp, and results in less than 1 hour!...
Medicine Products: